ELV Stock
Elevance Health, Inc.
—
Price
Daily closes via Alpaca (IEX); today's point is the latest trade.
Key stats
Valuation
P/E (trailing)16.4
Forward P/E14.0
Price / sales0.4
Price / book1.9
EPS (12 mo)$23.46
Dividend yield1.24%
Beta0.62
Financial health last 12 months
Revenue growth+3.6%
Earnings growth-4.1%
Net margin+2.6%
Return on equity11.6%
Debt / equity0.69
Hover a figure for what it means.
Analyst ratings Nov 2026 · 28 analysts
Consensus: Buy
Strong buy 7Buy 12
Hold 9Sell 0
Strong sell 0
| Month | Buy | Hold | Sell | Consensus |
|---|---|---|---|---|
| Nov 2026 | 19 | 9 | 0 | Buy |
| Oct 2026 | 19 | 9 | 0 | Buy |
| Sep 2026 | 19 | 10 | 0 | Buy |
| Aug 2026 | 19 | 10 | 0 | Buy |
Latest news
Holding UnitedHealth At $330? Its Past Falls Mostly Healed
Yahoo · 1d ago
Can UnitedHealth Group Stock Rally 50% After This Dip?
Yahoo · 1d ago
What Argus Sees in Elevance Health (ELV) for 2027
Yahoo · 2d ago
UnitedHealth Stock Slips: What's Going On?
Benzinga · 2d ago
Why Is Humana Stock Falling?
Yahoo · 2d ago
What Just Happened To UnitedHealth Stock?
Yahoo · 2d ago
Headlines from the last 10 days via Finnhub; links open the publisher's article.
Next earnings
No report scheduled in the next 4 months.
Past earnings moves
No tracked reports yet. TradeSphere saves the expected and actual move for every report from Nov 3, 2026 on, for stocks on the Earnings page.